Sharon Y. Eubanks honored for her leadership in tobacco control

Prevent Cancer Foundation® presents Eubanks with James L. Mulshine, M.D. Leadership Award

Published on November 9, 2018


Alexandria, Va. – The Prevent Cancer Foundation® honored Sharon Y. Eubanks, Of Counsel at The Henderson Firm, with the James L. Mulshine, M.D. Leadership Award. The award was presented on November 5, 2018, at the 15th annual Quantitative Imaging Workshop: Lung Cancer, COPD and Cardiovascular Disease.

Eubanks has been a leader in the fight against big tobacco for more than a decade. As lead council in the federal tobacco litigation, United States v. Philip Morris USA, et al., her work helped convict major U.S. tobacco companies of massive fraud and violation of the Racketeer Influenced and Corrupt Organizations (RICO) Act. As a result, tobacco companies were forced to change their marketing and advertising to include the dangers of nicotine and smoking.

“Smoking is the leading cause of lung cancer. By hiding this fact, big tobacco put millions of lives at risk,” said Carolyn Aldigé, Founder and CEO of the Prevent Cancer Foundation®. “We are so grateful to Sharon Eubanks for the instrumental role she played in changing the tobacco industry’s deceptive practices and getting people the message that smoking kills.”

In addition to her counsel and co-authorship of “Bad Acts: The Racketeering Case Against the Tobacco Industry,” Eubanks continues to put pressure on the tobacco industry as a member of the Advisory Committee for the Center for Tobacco Control Research and Education at the University of California, San Francisco, and a board member and officer of Americans for Nonsmokers’ Rights.

“Large companies and industries have a lot of money to bring to any fight that you’re undertaking, whether you’re the government, or private companies, or private individuals. But, often times, that doesn’t mean that they’re going to beat you, that they’re going to win, that they’re going to prevail. When you’re in a court of law, it’s justice that prevails. And that’s what happened in our case.”

Sign up to get the latest about cancer prevention and early detection directly in your inbox.